These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9187525)

  • 1. Cationic lipophilic drugs: mechanisms of action, potential consequences, and reversibility.
    Kacew S; Reasor MJ; Ruben Z
    Drug Metab Rev; 1997; 29(1-2):355-68. PubMed ID: 9187525
    [No Abstract]   [Full Text] [Related]  

  • 2. Perspectives on intracellular storage and transport of cationic-lipophilic drugs.
    Ruben Z; Rorig KJ; Kacew S
    Proc Soc Exp Biol Med; 1993 Jun; 203(2):140-9. PubMed ID: 8502654
    [No Abstract]   [Full Text] [Related]  

  • 3. Cellular accumulation and lipid binding of perfluorinated alkylated substances (PFASs) - A comparison with lysosomotropic drugs.
    Sanchez Garcia D; Sjödin M; Hellstrandh M; Norinder U; Nikiforova V; Lindberg J; Wincent E; Bergman Å; Cotgreave I; Munic Kos V
    Chem Biol Interact; 2018 Feb; 281():1-10. PubMed ID: 29248446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible implications in the use of exogenous phospholipids.
    Gregoriadis G; Siliprandi N; Turchetto E
    Life Sci; 1977 Jun; 20(11):1773-85. PubMed ID: 327178
    [No Abstract]   [Full Text] [Related]  

  • 5. Reevaluating equilibrium and kinetic binding parameters for lipophilic drugs based on a structural model for drug interaction with biological membranes.
    Mason RP; Rhodes DG; Herbette LG
    J Med Chem; 1991 Mar; 34(3):869-77. PubMed ID: 2002467
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationships between the release of soluble drugs from HPMC matrices and the physicochemical properties of drugs.
    Fu XC; Liang WQ; Ma WX
    Pharmazie; 2003 Mar; 58(3):221-2. PubMed ID: 12685821
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetic properties and their relation to certain physicochemical properties.
    Seydel JK
    Eur J Toxicol Hyg Environ; 1972; 5(5 Suppl):39-52. PubMed ID: 14732950
    [No Abstract]   [Full Text] [Related]  

  • 8. Rate-controlled drug dosage.
    Urquhart J
    Drugs; 1982 Mar; 23(3):207-26. PubMed ID: 7042294
    [No Abstract]   [Full Text] [Related]  

  • 9. [Physicochemical involvement in pharmacokinetic processes].
    Botrè C; Guidotti M
    Boll Chim Farm; 1978 Apr; 117(4):189-216. PubMed ID: 743369
    [No Abstract]   [Full Text] [Related]  

  • 10. Liposomes as drug carriers.
    Fendler JH; Romero A
    Life Sci; 1977 Apr; 20(7):1109-20. PubMed ID: 403379
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug absorption and bioavailability problems of tablets and capsules].
    Cascioli D; Petrangeli B
    Boll Chim Farm; 1978 Aug; 117(8):437-51. PubMed ID: 743388
    [No Abstract]   [Full Text] [Related]  

  • 12. Characteristics of drugs that penetrate the preimplantation blastocyst.
    Thithapandha A
    Biochem Pharmacol; 1980 Jun; 29(12):1663-8. PubMed ID: 7406895
    [No Abstract]   [Full Text] [Related]  

  • 13. Dosage adjustment in renal insufficiency.
    Mawer GE
    Br J Clin Pharmacol; 1982 Feb; 13(2):145-53. PubMed ID: 7059411
    [No Abstract]   [Full Text] [Related]  

  • 14. [Modification of the properties of drugs combined with polymers. II].
    Virnik AD; Snezhko VA; Khomiakov KP
    Polim Med; 1977; 7(1):27-55. PubMed ID: 887524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of drug-lipid complex formation by a high-throughput Langmuir-balance and correlation to phospholipidosis.
    Vitovic P; Alakoskela JM; Kinnunen PK
    J Med Chem; 2008 Mar; 51(6):1842-8. PubMed ID: 18318464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of drug-membrane interactions using the liposome system.
    Tritton TR; Murphere SA; Sarotorelli AC
    Biochem Pharmacol; 1977 Dec; 26(24):2319-23. PubMed ID: 597321
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipophilic ion exchangers for group separation of conjugated metabolites of xenobiotics.
    Sjövall J; Rafter J; Larsen G; Egestad B
    J Chromatogr; 1983 Aug; 276(1):150-6. PubMed ID: 6672008
    [No Abstract]   [Full Text] [Related]  

  • 18. [All-purpose indicator electrode for potentiometric titrations of both cationic and anionic type drugs].
    Yao SZ; Ma ML; Nie LH
    Yao Xue Xue Bao; 1988 Mar; 23(3):189-95. PubMed ID: 3421107
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening for the drug-phospholipid interaction: correlation to phospholipidosis.
    Alakoskela JM; Vitovic P; Kinnunen PK
    ChemMedChem; 2009 Aug; 4(8):1224-51. PubMed ID: 19551800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Systematic presentation of rational research on new drugs].
    Ariëns EJ
    Farmaco Sci; 1968 Jan; 23(1):52-94. PubMed ID: 4892131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.